Allergy Pollen
10
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
Validation and Reproducibility of S.P.A.T. With Allergens
Allergy Diagnostic Test Based on Microchip Technology
Mometasone Furoate Nasal Spray in Italian Children
Iron and Pollen Allergy in Women
Microassay and Allergy Skin Prick Test Correlation Study
Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis